Jack B. Prothero | Searcharxiv

arXiv2024

Data Integration Via Analysis of Subspaces (DIVAS)

Modern data collection in many data paradigms, including bioinformatics, often incorporates multiple traits derived from different data types (i.e. platforms). We call this data multi-block, multi-view, or multi-omics data. The emergent field of data integration develops and applies new methods for studying multi-block data and identifying how different data types relate and differ. One major frontier in contemporary data integration research is methodology that can identify partially-shared structure between sub-collections of data types. This work presents a new approach: Data Integration Via Analysis of Subspaces (DIVAS). DIVAS combines new insights in angular subspace perturbation theory with recent developments in matrix signal processing and convex-concave optimization into one algorithm for exploring partially-shared structure. Based on principal angles between subspaces, DIVAS provides built-in inference on the results of the analysis, and is effective even in high-dimension-low-sample-size (HDLSS) situations.

stat.ME↗

arXiv2021

New Perspectives on Centering

Data matrix centering is an ever-present yet under-examined aspect of data analysis. Functional data analysis (FDA) often operates with a default of centering such that the vectors in one dimension have mean zero. We find that centering along the other dimension identifies a novel useful mode of variation beyond those familiar in FDA. We explore ambiguities in both matrix orientation and nomenclature. Differences between centerings and their potential interaction can be easily misunderstood. We propose a unified framework and new terminology for centering operations. We clearly demonstrate the intuition behind and consequences of each centering choice with informative graphics. We also propose a new direction energy hypothesis test as part of a series of diagnostics for determining which choice of centering is best for a data set. We explore the application of these diagnostics in several FDA settings.

stat.ME↗